Thomas Connolly Net Worth

The estimated Net Worth of Thomas Connolly is at least $1.81 Miliardo dollars as of 13 June 2019. Thomas Connolly owns over 13,726,411 units of Avantor stock worth over $1,584,506,816 and over the last 6 years Thomas sold AVTR stock worth over $223,504,553.

Thomas Connolly AVTR stock SEC Form 4 insiders trading

Thomas has made over 2 trades of the Avantor stock since 2019, according to the Form 4 filled with the SEC. Most recently Thomas sold 13,726,411 units of AVTR stock worth $218,249,935 on 13 June 2019.

The largest trade Thomas's ever made was selling 13,726,411 units of Avantor stock on 13 June 2019 worth over $218,249,935. On average, Thomas trades about 4,682,729 units every 9 days since 2019. As of 13 June 2019 Thomas still owns at least 58,881,710 units of Avantor stock.

You can see the complete history of Thomas Connolly stock trades at the bottom of the page.

What's Thomas Connolly's mailing address?

Thomas's mailing address filed with the SEC is C/O GOLDMAN SACHS & CO. LLC, 200 WEST STREET, NEW YORK, NY, 10282.

Insiders trading at Avantor

Over the last 5 years, insiders at Avantor have traded over $3,149,576,044 worth of Avantor stock and bought 27,800 units worth $584,024 . The most active insiders traders include Mountain Investments Iii, L..., Jo Natauri e Sachs & Co. Llc Stone Bridg.... On average, Avantor executives and independent directors trade stock every 21 days with the average trade being worth of $48,107,115. The most recent stock trade was executed by Steven W Eck on 5 September 2024, trading 3,525 units of AVTR stock currently worth $88,337.

What does Avantor do?

based in center valley, pa (usa), avantor performance materials manufactures and markets high-performance chemistries and materials around the world under several respected brand names, including the j.t.baker®, macron fine chemicals™, rankem™, benesphera™, and poch™ brands. avantor products are used in a wide range of industries. our life sciences solutions are used in pharmaceutical production, laboratory research for academic, industry and quality control, and in medical lab testing. our electronics solutions are used in the manufacturing of semiconductors. for additional information please visit www.avantormaterials.com

Complete history of Thomas Connolly stock trades at Avantor

Avantor executives and stock owners

Avantor executives and other stock owners filed with the SEC include:

• Michael Stubblefield,
  President, Chief Executive Officer, Director
• Thomas Szlosek,
  Chief Financial Officer, Executive Vice President
• Michael Stubblefield,
  Pres, CEO & Director
• Gerard Brophy,
  Executive Vice President - Biopharma Production
• Devashish Ohri,
  Executive Vice President - AMEA
• Frederic Vanderhaegen,
  Executive Vice President - Americas and Europe
• Thomas A. Szlosek,
  Exec. VP & CFO
• Frederic Vanderhaegen,
  Exec. VP of Americas & Europe
• Dr. Gerald Brophy Ph.D.,
  Exec. VP of Biopharma Production
• Michael Wondrasch,
  Exec. VP & Chief Information Officer
• Rajiv Gupta,
  Chairman of the Board
• Jonathan Peacock,
  Independent Director
• Christi Shaw,
  Independent Director
• Rakesh Sachdev,
  Independent Director
• Juan Andres,
  Independent Director
• Gregory Summe,
  Independent Director
• Michael Severino,
  Independent Director
• Jo Natauri,
  Director
• Andre Moura,
  Director
• Matthew Holt,
  Director
• Steven Eck,
  Senior Vice President, Chief Accounting Officer
• Mark Murray,
  Executive Vice President of the Biomaterials and Advanced Technologies Platform
• Sven Henrichwark,
  Executive Vice President of APAC
• Tanya Foxe,
  Executive Vice President - Global Operations and Supply Chain
• Christophe Couturier,
  Executive Vice President - Services, Strategy and Business Transformation
• James Bramwell,
  Executive Vice President - Strategic Partners
• Justin Miller,
  Executive Vice President, General Counsel, Secretary
• Michael Wondrasch,
  Executive Vice President, Chief Information Officer
• Eric McAllister,
  Chief Human Resource Officer, Executive Vice President
• Allison K. Hosak,
  Sr. VP of Global Communications & Brand
• Justin M. Miller Esq.,
  Exec. VP, Gen. Counsel & Sec.
• Tommy J. Thomas CPA,
  VP of Investor Relations
• Steven W. Eck,
  Sr. VP, Corp. Controller & Chief Accounting Officer
• Sheri Lewis,
  Exec. VP, Global Operations & Supply Chain
• Lan Kang,
  Director
• John Carethers,
  Director
• Sachs & Co. Llc Stone Bridg...,
  
• Sachs & Co. Llc Stone Bridg...,
  
• Sheri Lewis,
  EVP, Global Ops & Supply Chain
• Mountain Investments Iii, L...,
  
• Mala Murthy,
  Director
• Brittany Hankamer,
  EVP, Chief HR Officer
• Randy Lee Stone,
  EVP, Laboratory Solutions
• Corey Walker,
  President Laboratory Solutions
• Ashish Kulkarni,
  See Remarks
• Sachs & Co. Llcgoldman Sach...,
  
• Meghan Henson,
  EVP, Chief HR Officer
• Thomas Connolly,
  Director
• Joseph R Massaro,
  Director
• Kitty Sahin,
  EVP, Strategy&Corp Development
• Claudius Sokenu,
  EVP, Chief Legal & Compliance
• R. Brent Jones,
  EVP, Chief Financial Officer
• Benoit Gourdier,
  EVP, Biopharma Production